Accelerated Technologies Partners
6
12M
3
0.50
3
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The current fund was established by Yuval Binur.
We can highlight the next thriving fund investment areas, such as Manufacturing, Medical Device. Among the various public portfolio startups of the fund, we may underline Mitralign, Impella Cardiosystems For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Accelerated Technologies Partners, startups are often financed by Oxford Bioscience Partners, Giza Venture Capital, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, Giza Venture Capital, Commons Capital. In the next rounds fund is usually obtained by Oxford Bioscience Partners, Triathlon Medical Venture Partners, Giza Venture Capital.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2003. The increased amount of exits for fund were in 2005. This Accelerated Technologies Partners works on 4 percentage points more the average amount of lead investments comparing to the other organizations.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 3
- Follow on index
- 0.50
- Investments by industry
- Health Care (6)
- Medical (3)
- Medical Device (3)
- Health Diagnostics (2)
- Genetics (2) Show 2 more
- Investments by region
-
- Germany (1)
- United States (5)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Claros Diagnostics | 19 Jan 2007 | Health Care, Health Diagnostics, Genetics | Early Stage Venture | 7M | United States, Florida, Miami |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.